Hepatitis C virus (HCV) load is one of the most important predictive factors of response to interferon treatment. However, little is known about the mode and determinants of viremia. The mode of viremia was investigated in 78 patients with chronic HCV genotype 1b infection during 1-2 years follow up
Genetic changes in the interferon sensitivity determining region of hepatitis C virus during the natural course of chronic hepatitis C
β Scribed by Shinya Maekawa; Nobuyuki Enomoto; Masayuki Kurosaki; Kazuyoshi Nagayama; Fumiaki Marumo; Chifumi Sato
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 257 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Interferon β£ (IFN β£) can suppress the replication of hepatitis C virus (HCV) in chronically infected patients. However, HCV persists in a significant number of patients despite the normalization of alanine transaminase (ALT) during IFN β£ therapy. In this study, HCV variants in patients under IFN β£ t
The hepatitis C virus (HCV) interferon-β£ (IFN-β£) sensitivity-determining region (ISDR) has been shown to suppress double-stranded RNAdependent protein kinase (PKR) activity in vitro in a yeast PKR expression system. Since variability of ISDR was shown to correlate with nonresponsiveness to IFN-β£ the
Detection and quantification of hepatitis C virus (HCV) RNA levels by using the standardized qualitative Amplicorβ’ HCV and quantitative Amplicor HCV Monitorβ’ assays (Roche Molecular Systems) were evaluated in 48 patients with chronic hepatitis C treated with interferon. Results were compared with an